S
Shakuntala
About Shakuntala
Data last updated:
Shakuntala is a Director at Desons Therapeutics Private Limited (since 2019). The company operates in Pharma. Desons Therapeutics Private Limited reported revenue of ₹3.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Desons Therapeutics Private Limited U74140HR2014PTC052104 | Director | 14 Aug 2019 | 2014 | ₹3.25 Cr (FY 2024) | Active |
Board colleagues of Shakuntala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kanchan Popli | 06787019 | Desons Therapeutics Private Limited | Director |
| Prem Raj | 06787029 | Desons Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shakuntala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shakuntala
Shakuntala currently holds 1 directorship: Desons Therapeutics Private Limited (Director, since 14 Aug 2019, revenue ₹3.25 Cr (FY 2024)).
Shakuntala was first appointed on 14 Aug 2019 as Director at Desons Therapeutics Private Limited.
The current boards of Shakuntala's companies include Kanchan Popli (Desons Therapeutics Private Limited), Prem Raj (Desons Therapeutics Private Limited).